About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
ISSN 2073–4034
eISSN 2414–9128
About
About journalGoals and objectivesEditorial councilContacts
ArchiveSubscription
To Authors
Copyright agreementProcedure for reviewingRequirements for publicationsSend articlePrivacy DeclarationConflicts of Interest DeclarationCriteria for authorship
Ethical Standards
Logout
Year
2025202420232022202120202019201820172016201520132012201120102009200820072006200520042003200220012000
Edition number
№20 (293)№19 (292)№18 (291)№17 (290)№16 (289)№s8-14№15 (288)№s5-14№14 (287)№s6-14№13 (286)№s7-14№12 (285)№11 (284)№10 (283)№9 (282)№8 (281)№s3-14№s4-14№7 (280)№6 (279)№4 (277)№3 (276)№2 (275)№s1-14№1 (274)

№5 (278) / 2014

V.I. Kudinov, M.S. Nichitenko, A.I. Chesnikova
THERAPY WITH LIRAGLUTIDE SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL AND HAS POSITIVE IMPACT ON THE CARDIOVASCULAR SYSTEM OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
13-18
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
19-25
M.B. Antsiferov (1), V.S. Pronin (2)
ANTITUMOR EFFECTS OF SOMATOSTATIN ANALOGUES IN SOMATOTROPH PITUITARY ADENOMAS: REVIEW OF RECENT RESEARCH
26-31
А.А. Yuryatin
THE SAVOR TRIAL: THE BEGINNING OF THE NEW ERA OF SAFE PHARMACOTHERAPY FOR TYPE-2 DIABETES MELLITUS
32-35
G.R. Galstyan
DETERMINATION OF GLYCEMIA IN THE SETTINGS OF MEDICAL PREVENTIVE INSTITUTION
36-39
E.V. Biryukova
CENTRAL DIABETES INSIPIDUS: WHAT IS THE SECRET OF TREATMENT EFFECTIVENESS?
40-46
N.A. Petunina , I.A. Kuzina
METFORMIN - A RELIABLE PARTNER IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
47-52
M.E.Statsenko (1), A.A.Vinnikova (1), N.N.Shilina (1), A.M.Ronskaya (2)
POTENTIALS OF DIBICOR IN IN CORRECTION OF METABOLIC AND VASCULAR ABNORMALITIES IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
53-60
O.L.Badalyan , A.A.Savenkov
PATHOGENETIC APPROACHES TO THE THERAPY OF DIABETIC POLYNEUROPATHY
61-65
L.A. Sharonova (1), A.F. Verbovoy (1), D.Yu. Sharonova (2)
CLINICAL MANIFESTATION, DIAGNOSIS AND TREATMENT OF DIABETIC NEUROPATHY
66-71
I.A. Kurnikova
FOROSA IN THE THERAPY OF CALCIUM AND PHOSPHORUS METABOLISM DISORDERS IN ENDOCRINOLOGICAL PATIENTS
72-80
M.B. Antsiferov, O.M. Koteshkova
DIABETES MANAGEMENT: THE IMPORTANCE OF STRUCTURED SELF-CONTROL
81-85
I.V. Kononenko, O.M. Smirnova
DIABETES MELLITUS: FROM UNDERSTANDING OF CAUSES TO THE CHOICE OF TREATMENT
86-93
N.Yu. Arbatskaya (1,2)
FEATURES OF GLUCOSE-LOWERING TREATMENT DURING PREGNANCY
94-99
Yu.E. Azimova (1,2)
DIABETIC POLYNEUROPATHY: APPROACHES TO THE THERAPY
100-103
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.